Sislax Pharma Private Limited

Produces and sells allopathic pharmaceuticals, including basic drugs, medicals, and chemicals.

1995 | Ut, Chandigarh (India) | Active
Last Updated:

Sislax Pharma Profile

Key Indicators

  • Authorised Capital ₹ 5.00 M
  • Paid Up Capital ₹ 5.00 M
  • Company Age 29 Year, 10 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 13.65 Cr
  • Satisfied Charges ₹ 4.29 Cr
  • Revenue Growth 10.15%
  • Profit Growth 145.03%
  • Ebitda 229.83%
  • Net Worth 7.73%
  • Total Assets -4.45%

About Sislax Pharma

Sislax Pharma Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 April 1995 and has a history of 29 years and ten months. Its registered office is in Ut, Chandigarh.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.

The company currently has active open charges totaling ₹13.65 Cr. The company has closed loans amounting to ₹4.29 Cr, as per Ministry of Corporate Affairs (MCA) records.

Usha Vig, Sunanda Gupta, and Satish Bamba serve as directors at the Company.

Company Details

  • Location Ut, Chandigarh
  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    sislax.com

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24232CH1995PTC016300

  • Company No.

    016300

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    26 Apr 1995

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Chandigarh

Industry

Pharma

Who are the key members and board of directors at Sislax Pharma?

Financial Performance of Sislax Pharma.

Sislax Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.15% increase. The company also saw a substantial improvement in profitability, with a 145.03% increase in profit. The company's net worth moved up by a moderate rise of 7.73%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
10.15%
Revenue from Operations
10.58%
Total Assets
-4.45%
Profit or Loss
145.03%
Net Worth
7.73%
EBITDA
229.83%

What is the Ownership and Shareholding Structure of Sislax Pharma?

In 2023, Sislax Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹136.50 M

Satisfied Charges

₹42.90 M

Charges Breakdown by Lending Institutions

  • Others : 13.65 Cr

Latest Charge Details

DateLenderAmountStatus
19 Jun 2024Others₹8.00 CrOpen
14 May 2012Others₹5.65 CrOpen
02 Mar 2005Canara Bank₹3.40 CrSatisfied
02 Mar 2005Canara Bank₹2.50 MSatisfied
29 Apr 2004Canara Bank₹1.40 MSatisfied

How Many Employees Work at Sislax Pharma?

Sislax Pharma has a workforce of 24 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sislax Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sislax Pharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Sislax Pharma

Recent activity within the organization

  • Annual General Meeting

    Sislax Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

    30 Sep 2024

  • Charges

    A charge with Others amounted to Rs. 80.00 M with Charge ID 100960348 was registered on 19 Jun 2024.

    19 Jun 2024

  • Balance Sheet

    Sislax Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh.

    31 Mar 2024

  • Charges

    A charge with Others of Rs. 56.50 M registered on 14 May 2012 with Charge ID 10360753 was modified on 04 Jun 2020.

    04 Jun 2020

  • Director Appointment

    Satish Bamba was appointed as a Director was appointed as a Director on 31 Oct 2017 & has been associated with this company since 7 years 4 months .

    31 Oct 2017

  • Director Appointment

    Sunanda Gupta was appointed as a Director was appointed as a Director on 02 Feb 2015 & has been associated with this company since 10 years 27 days .

    02 Feb 2015

Frequently asked questions

  • What is the Incorporation or founding date of Sislax Pharma Private Limited?

    Sislax Pharma Private Limited was incorporated on 26 Apr 1995.

  • What is authorized share capital and paid-up capital of Sislax Pharma Private Limited?

    The authorized share capital of Sislax Pharma Private Limited is ₹ 5.00 M and paid-up capital is ₹ 5.00 M.

  • Who are the current board members & directors of Sislax Pharma Private Limited?

    Currently 3 directors are associated with Sislax Pharma Private Limited.

    • Usha Vig
    • Sunanda Gupta
    • Satish Bamba

  • What is the registered address of Sislax Pharma Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Sislax Pharma Private Limited is H No 2554Sector 35 C India, Ut, Chandigarh.

  • What is the corporate identification number (CIN) and company number of Sislax Pharma Private Limited?

    The corporate identification number (CIN) of Sislax Pharma Private Limited is U24232CH1995PTC016300 and the company number is 016300 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Sislax Pharma Private Limited?

    The Official website of Sislax Pharma Private Limited is https://www.sislax.com

  • What has been the recent revenue trend for Sislax Pharma Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Sislax Pharma Private Limited has risen by 10.15%.

  • How many employees does Sislax Pharma Private Limited currently have?

    As Per 2023 financial reports, 24 employees are currently employed by Sislax Pharma Private Limited.

  • What change has been observed in the net worth of Sislax Pharma Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Sislax Pharma Private Limited has experienced an upsurge of 7.73%.

  • What are the total open charges for Sislax Pharma Private Limited?

    As per the financial statements for fiscal Year 2023, The total open charges for Sislax Pharma Private Limited amount to ₹ 13.65 Cr.

  • When was the last Balance Sheet of Sislax Pharma Private Limited filed with the ROC?

    The most recent Balance Sheet for Sislax Pharma Private Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Drug Formulation & Development